Aristides Capital’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Buy
+3,388
New +$315K 0.05% 174
2020
Q2
– Sell
-2,724
Closed -$271K – 136
2020
Q1
$271K Sell
2,724
-1,791
-40% -$194K 0.2% 78
2019
Q4
$519K Buy
+4,515
New +$546K 0.4% 105

Other funds holding HAE

Aristides Capital's HAE Position: Q3 2026 in Review

Aristides Capital opened a new position in Haemonetics (HAE) in Q3 2026: 3,388 shares worth $357K. The stake represents 0.05% of the portfolio and ranks #174 among its holdings. This is a return to the name: Aristides Capital previously reported a position in HAE as recently as Q1 2020.

Aristides Capital first reported a position in HAE in Q4 2019 and has held it in 3 quarters since. The position peaked at $519K in Q4 2019. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Aristides Capital held 3,388 shares of Haemonetics worth $357K as of Q3 2026.
  • Haemonetics was a new Aristides Capital position in Q3 2026.
  • Haemonetics made up 0.05% of Aristides Capital's portfolio in Q3 2026, its #174 holding.
  • Aristides Capital first reported a position in Haemonetics in Q4 2019 and has held it in 3 quarters since.
  • Aristides Capital's Haemonetics position peaked at $519K in Q4 2019.
  • 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Aristides Capital's 13F filing for Q3 2026, filed 16 Nov 2026.